Dec. 19 at 4:18 PM
$EDAP dollar costing continues to bring great value! I owned this stock a decade back when it hooved at
$1 and peaked at
$12. Along the way, if had to bring my average cost back down. I’m few dollars away but have not sold any shares. Among various stocks I hold, this Med Tech stock has intrigued me with insights. So much news on Prostate Cancer being a headline concern. I realize this is small forum of followers with different views. With years of knowledge and investments. This is a buy now if you want capitalized return. EDAP is a buy under
$5 as its intrinsic value at consolidation will be near
$20. Window narrows this month at today’s levels as US listing opens the paradox forward.